470 top medical experts on Neurofibromatosis 2 across 36 countries and 33 U.S. states, including 360 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Neurofibromatosis 2: An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (neurilemmoma) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene (genes, neurofibromatosis 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Acoustic Neuroma (2,296), Neurofibromatoses (1,473).
  4. Clinical Trials ClinicalTrials.gov : at least 37 including 3 Active, 20 Completed, 9 Recruiting
  5. Synonyms: Bilateral Acoustic Neurofibromatosis,  NF2 Central Neurofibromatosis,  Bilateral Acoustic Neuroma,  Bilateral Acoustic Schwannoma


  

        

                    


    Computing Expert Listing ...

);